Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity Hospital, Montpellier

About this trial

The hypothesis of this trial is that the absence of systematic bladder catheterization in patients performing spontaneous urination in the hour preceding the planned cesarean section under spinal anesthesia would not lead to more bladder heterocatheterization for postpartum urinary retention (RUPP) in the 24 hours post-cesarean section than systematic intraoperative bladder catheterization up to 2 hours post-surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patient

Patient admitted for a planned cesarean section after 34 weeks under spinal anesthesia

Single or twin pregnancy

Unscarred or with one or two scars of the uterus

Disqualifiers

Positive urine test strip showing a presence of nitrites or leukocytes, the day before the surgery suggesting asymptomatic bacteriuria

Emergency Caesarean

Scheduled Caesarean section with intervention delayed beyond 3 p.m. for service organization reasons

Epidural anesthesia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Spontaneous urination during the hour before caesarean section.

    Procedure/Surgery

    Patients will be asked to urinate by spontaneous urination in the hour before the cesarean section with a cytobacteriological urine examination (ECBU) carried out. An ultrasound check by Bladderscan of the post-void residue will be carried out as soon as the patient will be installed on the intervention table. In the event of post-void residue of more than 150 ml, favoring urinary infections, the patient will be excluded from the research.

  • Systematic bladder catherization during caesarean section.

    Procedure/Surgery

    After implementation of loco-regional analgesia by spinal anesthesia, the patient will be positioned, with a perineal toilet and installation of a bladder catheter type Foley ch. 16.

Treatment groups

550 Participants
are divided into 2 treatment groups
Group A: Arm A: Intraoperative bladder catheterizationActive comparator 2 interventions
Group B: Arm B: Absence of intraoperative bladder catheterizationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Necessity of heterocatheterization within 24 hours following the cesarean section.

Heterocatheterization is indicated in cases of Complete postpartum urinary retention (RUPP-C) or in cases of Partial postpartum urinary retention (RUPP-P) with a post-void residue (measured by Bladder scan) greater than the volume urinated (measured in a graduated jar), provided the volume urinated exceeds 150 ml.

Time frame
Between Hour 0 (time of surgical closure) and Hour 24

Secondary outcomes

1

Experience of childbirth

The participant's experience of childbirth will be assessed using the Questionnaire For Assessing the Childbirth Expérience (QEVA) built in 26 items: Score result: D1: Emotions during childbirth (Items 1, 2, 3, 4 and 24) D2: Interactions with healthcare professionals (Items 5, 6, 7, 8 and 9) D3: First moments with the child (Items 17, 18 and 19) D4: Delayed emotions (Items 20, 21, 22, 23)

Time frame
Hour 24
2

Duration of preoperative preparation

The duration of preoperative preparation (min) will be measured from entry into the operating room to the incision.

Time frame
Between entering the surgery room and incision during the surgical procedure
3

Operating time

Operating time (in minutes) corresponds to the period between incision and surgical closure (H0).

Time frame
During surgery (Between incision and surgical closure)
4

Duration of post-operative hospitalization

Duration of post-operative hospitalization (in days and hours) corresponds to the period between surgical closure (H0) and discharge from hospitalization.

Time frame
Discharge from hospitalization (Maximum 1 month after the cesarean section)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.